DePuy Synthes Aims to Improve Operations with Ortho Restructure
Our chart of the month tracks DePuy Synthes’ sales by business unit from 2016 through our 2023 projection....
Our chart of the month tracks DePuy Synthes’ sales by business unit from 2016 through our 2023 projection....
We spoke with Anika President and CEO Cheryl Blanchard, Ph.D. about the RevoMotion launch, ASCs, and robotics in the shoulder...
Xtant Medical's CEO has turned around the company by reengaging the team, optimizing business processes and acquiring products....
The company grew in the mid-teens in 3Q23 and sees competitors putting less focus on treating pediatric trauma and deformity....
The company notched its fifth consecutive quarter with more than 20% growth and is on track for arthroscopic MACI delivery...
The loose cortical fibers are engineered to complement specific surgical applications in the foot and ankle and are flexible upon...
The staple features an ultra-low-profile bridge with increased surface area to enhance stability while minimizing soft tissue irritation. ...
The company grew 61% as-reported in the third quarter of 2023, or 1.2% on a pro forma basis including prior...
The company grew in the mid-teens during the third quarter of 2022, driven by sales force and active surgeon base...
The company grew more than 23% in 3Q23 but ultimately reduced its guidance because of higher-than-expected seasonality during the summer....
Login
Register for a free account
As a guest member you get access to more articles and videos every month.